Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Expert Opinion on Drug Metabolism & Toxicology|February 19, 2020
DNA inhibitors for the treatment of brain tumorsLucia Lisi, Marta Chiavari, Gabriella Maria Pia Ciotti, et al.
The Journal of Nutrition|December 30, 2004
beta-Carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cellsPaola Palozza, Simona Serini, Nicola Maggiano, et al.
Molecular and Cellular Endocrinology|May 13, 2009
Expression and subcellular localization of CRH and its receptors in human endometrial cancerFiorella Miceli, Franco O Ranelletti, Enrica Martinelli, et al.
EXCLI Journal|October 25, 2019
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cellsNatalia Cappoli, Daniele Mezzogori, Elisabetta Tabolacci, et al.
Neuroreport|June 2, 2006
Protective properties of idebenone in noise-induced hearing loss in the guinea pigBruno Sergi, Anna Rita Fetoni, Gaetano Paludetti, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 13, 2004
The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in ratsAline S C Fabricio, Fabiane H Veiga, Rodrigo Cristofoletti, et al.
International Journal of Molecular Sciences|November 25, 2023
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19Giuseppe Tringali, Michela Pizzoferrato, Lucia Lisi, et al.
Neuropharmacology|December 29, 2009
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociceptionAlessandro Capuano, Alice De Corato, Mariangela Treglia, et al.
Oncology Reports|March 22, 2008
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanomaLucio Tentori, Annalisa Susanna Dorio, Alessia Muzi, et al.
Journal of Neuroimmunology|November 6, 2012
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAELucia Lisi, Susan McGuire, Anthony Sharp, et al.
Pageof 15